Transcranial Magnetic Stimulation for Alcoholism
(TMS Trial)
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial explores the use of transcranial magnetic stimulation (TMS), a non-invasive technique that affects brain activity, to help treat alcohol use disorder (AUD). Researchers aim to understand how TMS impacts brain circuits involved in AUD, hoping to find new management strategies for this condition. Participants will receive different combinations of TMS, including some sessions with inactive (sham) treatment for comparison. The trial seeks individuals who either consume a lot of alcohol or do not drink heavily at all. As an unphased trial, it offers participants the opportunity to contribute to groundbreaking research that could lead to innovative treatments for AUD.
Will I have to stop taking my current medications?
The trial requires that participants do not take medications known to affect alcohol intake or craving, and those that lower the seizure threshold. If you are on such medications, you may need to stop taking them to participate.
Is there any evidence suggesting that this trial's treatments are likely to be safe?
Research has shown that Transcranial Magnetic Stimulation (TMS) is generally safe and well-tolerated for individuals with substance use disorders, including alcohol use disorder. Most experience only mild side effects, with headaches being the most common, which typically resolve on their own. Although there is a small risk of seizures, this remains rare. Studies indicate that the side effects of TMS in people with substance use issues resemble those in other groups, suggesting the treatment is manageable for most participants.12345
Why are researchers excited about this trial?
Researchers are excited about using Transcranial Magnetic Stimulation (TMS) for treating alcoholism because it offers a unique, non-invasive approach by directly stimulating specific regions of the brain. Unlike traditional treatments for alcoholism, which often involve medications like disulfiram or naltrexone that work by modifying the brain's chemical signals or reducing cravings, TMS targets the brain's neural activity through magnetic fields. This method could potentially provide quicker results with fewer side effects, making it a promising alternative for individuals who haven't responded well to standard treatments. Additionally, the trial explores different protocols, including variations in frequency and sequence of stimulation, which could help tailor the therapy to individual needs and optimize its effectiveness.
What evidence suggests that Transcranial Magnetic Stimulation could be an effective treatment for alcoholism?
Research has shown that transcranial magnetic stimulation (TMS), which participants in this trial may receive, can help reduce cravings and alcohol use in people with alcohol use disorder (AUD). Studies have found that TMS may lower the number of days people drink heavily. It uses magnetic fields to alter brain activity, affecting cravings and impulsive behavior. Some research also suggests that TMS can improve brain structure and function related to AUD. Overall, TMS is considered a promising tool for reducing alcohol consumption and cravings.26789
Who Is on the Research Team?
Merideth A Addicott, PhD
Principal Investigator
Wake Forest University Health Sciences
Are You a Good Fit for This Trial?
This trial is for individuals with Alcohol Use Disorder (AUD). To join, participants must have a certain score on the DSM-5 and AUDIT indicating they either consume little to no alcohol or are heavy alcohol consumers. Those who don't meet these specific criteria cannot participate.Inclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive TMS pulse sequences and undergo MEG scans to measure brain activity
Follow-up
Participants are monitored for adverse events potentially related to TMS
What Are the Treatments Tested in This Trial?
Interventions
- Transcranial Magnetic Stimulation (TMS)
Find a Clinic Near You
Who Is Running the Clinical Trial?
Wake Forest University Health Sciences
Lead Sponsor